HIV-1 Infection of Long-Lived Hematopoietic Precursors In Vitro and In Vivo
Sebastian Renelt,
Patrizia Schult-Dietrich,
Hanna-Mari Baldauf,
Stefan Stein,
Gerrit Kann,
Markus Bickel,
Ulrikke Kielland-Kaisen,
Halvard Bonig,
Rolf Marschalek,
Michael A. Rieger,
Ursula Dietrich,
Ralf Duerr
Affiliations
Sebastian Renelt
Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, 60596 Frankfurt, Germany
Patrizia Schult-Dietrich
Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, 60596 Frankfurt, Germany
Hanna-Mari Baldauf
Max von Pettenkofer Institute & Gene Center, Virology, National Reference Center for Retroviruses, Faculty of Medicine, LMU München, 81377 Munich, Germany
Stefan Stein
Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, 60596 Frankfurt, Germany
Gerrit Kann
Department of Medicine II/Infectious Diseases, Goethe University Hospital, 60596 Frankfurt, Germany
Markus Bickel
Infektiologikum, Center for Infectious Diseases, 60596 Frankfurt, Germany
Ulrikke Kielland-Kaisen
Department of Gynecology, Medical School, Goethe University, 60590 Frankfurt, Germany
Halvard Bonig
Institute for Transfusion Medicine and Immunohematology, German Red Cross Blood Donor Service Baden-Württemberg-Hessen, Goethe University, 60528 Frankfurt, Germany
Rolf Marschalek
Institute of Pharmaceutical Biology, Goethe University, 60438 Frankfurt, Germany
Michael A. Rieger
Department of Medicine, Hematology/Oncology, Goethe University Hospital, 60590 Frankfurt, Germany
Ursula Dietrich
Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, 60596 Frankfurt, Germany
Ralf Duerr
Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, 60596 Frankfurt, Germany
Latent reservoirs in human-immunodeficiency-virus-1 (HIV-1)-infected individuals represent a major obstacle in finding a cure for HIV-1. Hematopoietic stem and progenitor cells (HSPCs) have been described as potential HIV-1 targets, but their roles as HIV-1 reservoirs remain controversial. Here we provide additional evidence for the susceptibility of several distinct HSPC subpopulations to HIV-1 infection in vitro and in vivo. In vitro infection experiments of HSPCs were performed with different HIV-1 Env-pseudotyped lentiviral particles and with replication-competent HIV-1. Low-level infection/transduction of HSPCs, including hematopoietic stem cells (HSCs) and multipotent progenitors (MPP), was observed, preferentially via CXCR4, but also via CCR5-mediated entry. Multi-lineage colony formation in methylcellulose assays and repetitive replating of transduced cells provided functional proof of susceptibility of primitive HSPCs to HIV-1 infection. Further, the access to bone marrow samples from HIV-positive individuals facilitated the detection of HIV-1 gag cDNA copies in CD34+ cells from eight (out of eleven) individuals, with at least six of them infected with CCR5-tropic HIV-1 strains. In summary, our data confirm that primitive HSPC subpopulations are susceptible to CXCR4- and CCR5-mediated HIV-1 infection in vitro and in vivo, which qualifies these cells to contribute to the HIV-1 reservoir in patients.